Education
About Us
Working with TipRanks
Follow Us
Krystal Biotech (KRYS)
NASDAQ:KRYS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 290.51M | $ 50.70M | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 270.45M | $ 47.60M | $ -4.05M | $ -2.77M | $ -1.85M |
| Operating Income | $ 65.69M | $ -109.73M | $ -145.20M | $ -68.28M | $ -33.00M |
| EBITDA | $ 109.91M | $ 17.90M | $ -145.20M | $ -65.31M | $ -30.32M |
| Net Income | $ 89.16M | $ 10.93M | $ -139.97M | $ -69.57M | $ -32.17M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 597.52M | $ 532.18M | $ 379.17M | $ 438.10M | $ 271.26M |
| Total Assets | $ 1.06B | $ 818.36M | $ 558.45M | $ 626.29M | $ 310.84M |
| Total Debt | $ 7.26M | $ 8.09M | $ 8.93M | $ 8.02M | $ 11.55M |
| Net Debt | $ -337.60M | $ -350.23M | $ -152.97M | $ -333.22M | $ -256.72M |
| Total Liabilities | $ 109.46M | $ 39.71M | $ 36.22M | $ 32.72M | $ 18.76M |
| Stockholders' Equity | $ 946.38M | $ 778.64M | $ 522.23M | $ 593.58M | $ 292.08M |
| Cash Flow | |||||
| Free Cash Flow | $ 119.18M | $ -100.60M | $ -153.55M | $ -116.27M | $ -40.93M |
| Operating Cash Flow | $ 123.42M | $ -88.80M | $ -100.57M | $ -47.94M | $ -26.08M |
| Investing Cash Flow | $ -163.44M | $ 82.64M | $ -114.08M | $ -226.77M | $ -11.18M |
| Financing Cash Flow | $ 27.01M | $ 202.75M | $ 35.35M | $ 347.69M | $ 118.02M |